Here are the most active stocks on Tuesday mid-morning on the TSX and TSX Venture Exchange.
On Tuesday, the top TSX mover was
Talisman Energy Inc. (
TSX: T.TLM,
Stock Forum). The stock lost 1.0% and was trading at $13.02 on volume of 10.2 million.
On September 7, billionaire investor Carl Icahn disclosed that he had bought a 5.97% stake in the oil and gas company. The activist investor purchased the shares `in the belief that they were undervalued relative to the value of the issuer's underlying assets.''
Pacific Rim Mining Corp. (
TSX: T.PMU,
Stock Forum) was the second most active stock on the TSX. It gained 57.1% and was trading at $0.055 on volume of 5.5 million shares.
Today,
OceanaGold Corp. (
TSX: T.OGC,
Stock Forum) and Pacific Rim announced that the companies have entered into a definitive agreement pursuant to which OceanaGold has agreed to acquire all of the issued and outstanding common shares of Pacific Rim in an all-share transaction to be completed by way of a statutory plan of arrangement under the
Business Corporations Act. Pacific Rim's principal asset is the high-grade, El Dorado gold project in El Salvador.
Aldrin Resource Corp. (
TSX: V.ALN,
Stock Forum) was the volume leader on the TSX Venture Exchange. It gained 22.7% and was trading at $0.135 on volume of 3.6 million.
Today, the uranium exploration and development company announced a non-brokered private placement consisting of up to 10 million units at a price of $0.10 per unit for gross proceeds of $1.0 million. Proceeds of the financing will be used towards the Triple M property, located in the Athabasca Basin, Saskatchewan, exploration program and for general working capital.
Aldrin also announced an agreement to purchase 100% interest in the Virgin uranium property, a high-priority exploration property covering 49,275 hectares on the south-central margin of the Athabasca Basin, Saskatchewan.
The second most active stock on the TSX Venture was
ZoomMed Inc. (
TSX: V.ZMD,
Stock Forum). It rose 12.5% and was trading at $0.045 after 2.8 million shares changed hands.
On September 30, the medical software firm reported its 2013 annual financial results. Resulting from the efforts made since the beginning of its operations, the company recorded a profit, before proportionate share of the investee’s net results of $3.098 million for the fiscal year ended May 31, 2013 compared to a loss of $3.085 million for the fiscal year ended May 31, 2012 and a loss of $3.7 million for the fiscal year ended May 31, 2011.